Procalcitonin Levels in Patients with Juvenile Idiopathic Inflammatory Myopathies
Annals of Rheumatology and Autoimmunity · 2026-07 · 6 (3) · 94-100
DOI: 10.4103/ara.ara_28_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Rheumatology and Autoimmunity, online erschienen am 28.07.2026. Verfasst von Christopher Costin und 6 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Patients with juvenile idiopathic inflammatory myopathies (JIIMs) are at an increased risk of infection due to immunosuppression. Serum procalcitonin (PCT) is a biomarker for diagnosing bacterial infections. While no substantial studies have examined PCT in JIIM, it is slightly elevated in Still’s disease.
Objectives
We aimed to investigate whether PCT is elevated in active JIIM in the absence of bacterial infection. We conducted a cross-sectional study of 42 newly diagnosed JIIM patients, including 18 treatment-naïve individuals, and 21 healthy controls. Clinical assessments included disease activity scores (Total Disease Activity Score [DAS-T], Skin Disease Activity Score [DAS-S], Muscle Disease Activity Score [DAS-M]), and muscle strength (Childhood Myositis Assessment Scale). Laboratory evaluations covered muscle enzymes and inflammatory markers. Only five JIIM patients had detectable PCT levels (maximum 0.39 ng/mL), while all controls had undetectable levels. Median PCT levels did not significantly differ between JIIM patients and controls ( P = 0.16). Elevated neopterin showed a positive correlation with muscle weakness (DAS-M, r = 0.53, P = 0.002) and skin rash (DAS-S, r = 0.434, P = 0.012). All muscle enzymes correlated positively with DAS-M.
Conclusion
Most children with active JIIM had undetectable PCT levels. These findings suggest that moderate to high PCT elevations in JIIM patients are more likely due to infection than disease activity.
Zitieren
APA
Costin, C., Morgan, G., Muhammad, L. N., Chun, A., Klein-Gitelman, M., Lee, Y. C., & Khojah, A. (2026). Procalcitonin Levels in Patients with Juvenile Idiopathic Inflammatory Myopathies. Annals of Rheumatology and Autoimmunity, 6(3), 94-100. https://doi.org/10.4103/ara.ara_28_25
Vancouver
Costin C, Morgan G, Muhammad LN, Chun A, Klein-Gitelman M, Lee YC, et al. Procalcitonin Levels in Patients with Juvenile Idiopathic Inflammatory Myopathies. Annals of Rheumatology and Autoimmunity. 2026;6(3):94-100. doi:10.4103/ara.ara_28_25
BibTeX
@article{Costin2026,
author = {Costin, Christopher and Morgan, Gabrielle and Muhammad, Lutfiyya N. and Chun, Angela and Klein-Gitelman, Marisa and Lee, Yvonne C. and Khojah, Amer},
title = {Procalcitonin Levels in Patients with Juvenile Idiopathic Inflammatory Myopathies},
journal = {Annals of Rheumatology and Autoimmunity},
year = {2026},
volume = {6},
number = {3},
pages = {94--100},
doi = {10.4103/ara.ara_28_25}
}
EUVIMED